Dual-mode β-galactosidase-responsive AIE photosensitizer for selective imaging and ablation of senescent cells
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. Aging, cellular senescence, and cancer10.1146/annurev-physiol-030212-183653 ↗
2. Mechanisms and functions of cellular senescence10.1172/JCI95148 ↗
3. Cellular senescence: from physiology to pathology10.1038/nrm3823 ↗
4. Cellular senescence in development, regeneration and disease10.1242/dev.151837 ↗
5. The senescence-associated secretory phenotype: the dark side of tumor suppression10.1146/annurev-pathol-121808-102144 ↗
6. The role of senescent cells in ageing10.1038/nature13193 ↗
7. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan10.1038/nature16932 ↗
8. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs10.1111/acel.12344 ↗
9. Senescence in health and disease10.1016/j.cell.2017.05.015 ↗
10. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study10.1016/j.ebiom.2018.12.052 ↗
11. Senolytics improve physical function and increase lifespan in old age10.1038/s41591-018-0092-9 ↗
12. Photoactivatable senolysis with single-cell resolution delays aging10.1038/s43587-023-00360-x ↗
13. Molecularly targeted fluorescent sensors for visualizing and tracking cellular senescence10.3390/bios13090838 ↗
14. Developing a far-red fluorogenic β-galactosidase probe for senescent cell imaging and photoablation10.1039/D2RA00377E ↗
15. Cellular senescence imaging and senolysis monitoring in cancer therapy based on a β-galactosidase-activated aggregation-induced emission luminogen10.1016/j.actbio.2024.03.027 ↗
16. Noncancerous disease-targeting AIEgens10.1039/D2CS00610C ↗
17. Selective photodynamic eradication of senescent cells with a β-galactosidase-activated photosensitiser10.1039/D2CC06661K ↗
18. Trilocked photodynamic senolytic inducer potentiating immunogenic senescent cell removal for liver fibrosis resolution10.1021/jacs.5c03498 ↗
19. Recent developments in small-molecule fluorescent probes for cellular senescence10.3390/chemosensors12070141 ↗
20. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
21. Supramolecular photosensitizers rejuvenate photodynamic therapy10.1039/C7CS00594F ↗
22. Overcoming the Achilles' heel of photodynamic therapy10.1039/C6CS00616G ↗
23. A type I and type II chemical biology toolbox to overcome the hypoxic tumour microenvironment for photodynamic therapy10.1039/D4BM00319E ↗
24. Recent advances for enhanced photodynamic therapy: from new mechanisms to innovative strategies10.1039/D3SC07006A ↗
25. Innovative strategies for hypoxic-tumor photodynamic therapy10.1002/anie.201805138 ↗
26. Rhodamine B and rhodamine 101 as reference substances for fluorescence quantum yield measurements10.1021/j100451a030 ↗
27. Molecular chemiluminescent probes with a very long near-infrared emission wavelength for in vivo imaging10.1002/anie.202013531 ↗
28. Independent organelle and organelle–organelle interactions: essential mechanisms for malignant gynecological cancer cell survival10.3389/fimmu.2024.1393852 ↗